Post
Micron touts positive data from needle-free measles and rubella vaccine study
Life science company Micron Medical has published positive results from a Phase I/II study evaluating its measles and rubella microneedle …
“Defensibility” key for AI-centric small biotechs seeking investment
Building a robust framework around proprietary artificial intelligence (AI) platforms is critical for small biotechs seeking investment, according to a …
Genentech experts call for multiple strategies to diversify clinical trials
Amid a push in the biopharma industry to improve diversity in clinical trial enrolment, there is “no one single approach” …
US West Coast oncology clinical trials lead in diversity
The US West Coast has some of the most diverse oncology clinical trials in global healthcare, according to GlobalData’s Pharma …
SecondWave’s ultrasound therapy improves rheumatoid arthritis in pilot study
SecondWave has reported positive initial results from a pilot study investigating its wearable therapeutic ultrasound device to treat chronic and …
FDA approves Alecensa as leading-edge adjuvant therapy for ALK-positive lung cancer
On 18 April 2024, the US Food and Drug Administration (FDA) approved Roche’s Alecensa (alectinib), an oral anaplastic lymphoma kinase …
Aileron reports data from cohort one of Phase Ib inhaled IPF treatment trial
Aileron Therapeutics has reported positive outcomes from cohort one of the ongoing Phase Ib clinical trial of inhaled LTI-03 in …
Gilgamesh starts subject dosing in major depressive disorder trial
Gilgamesh Pharmaceuticals has commenced subject dosing in a Phase IIa clinical trial of GM-1020 to treat major depressive disorder (MDD). This …
BrioHealth wins FDA nod to trial BrioVAD ventricular assist device
BrioHealth Solutions has received investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) for its BrioVAD …
First cohort benefits from Atsena Therapeutics XLRS gene therapy
Atsena Therapeutics has announced positive preliminary data for its gene therapy candidate ATSN-201 for the treatment of X-linked retinoschisis (XLRS). The …
Kazia concludes first stage of Phase I advanced cancer treatment trial
Kazia Therapeutics has announced the successful completion of the first stage of the Phase I clinical trial of EVT801 monotherapy …
Merck reports data from Phase III gastric cancer treatment trial
Merck (MSD) has announced the final analysis findings from the Phase III KEYNOTE-811 clinical trial evaluating Keytruda (pembrolizumab) plus trastuzumab …
Project Optimus: helping or hindering cancer drug development?
Alongside the multitude of guidance documents, recent years have seen the US Food and Drug Administration (FDA) ramp up workshops …
OCT Southeast 2024: Industry leaders urged to embrace DCTs but avoid “system bloat”
While the decentralisation of clinical trials has been happening for a while, many in the industry are still not moving …
Liberate Medical starts neuromuscular stimulator trial with $6.5m grant
Liberate Medical has commenced patient enrolment in a study investigating its neuromuscular electrical stimulator to help respiratory failure patients wean …